CONTEXT: Sex steroid hormones may play a role in the pathogenesis of chronic kidney disease (CKD). OBJECTIVE: To determine whether sex steroid hormone concentrations are associated with kidney function or kidney damage in men in the general US population. We hypothesized that lower serum testosterone and E(2) concentrations are associated with CKD. DESIGN PATIENTS AND MEASUREMENTS: Serum sex steroid hormones were measured by electrochemiluminescence immunoassays for 1470 men who attended the morning session of Phase I of the Third National Health and Nutrition Examination Survey (NHANES III). We used two measures of CKD, estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m(2) calculated using serum creatinine or cystatin C levels and the abbreviated Modification of Diet in Renal Disease Study formulae and urinary albumin : creatinine ratio (UACR) >or= 17 mg/g. RESULTS: Mean free testosterone concentration was higher in men with an eGFR < 60 ml/min/1.73 m(2) than in men with a higher eGFR. In multivariable adjusted models, the odds of an eGFR < 60 ml/min/1.73 m(2) or UACR >/= 17 mg/g did not differ across tertiles of hormones with the exception of free E(2); those in the highest vs. lowest tertile had an elevated odds of decreased eGFR (OR: 3.04, 95% CI (1.22, 7.57); P-trend = 0.02). CONCLUSIONS: In a nationally representative sample of US adult men, higher free E(2) concentration was significantly associated with an eGFR < 60 ml/min/1.73 m(2) as assessed by serum creatinine or cystatin C even after multivariable adjustment. These findings are in contrast to the hypothesis that oestrogens may protect against CKD, though reverse causation cannot be ruled out. Longitudinal investigation of the role of oestrogens in kidney haemodynamics, function, and pathophysiology is warranted.
CONTEXT: Sex steroid hormones may play a role in the pathogenesis of chronic kidney disease (CKD). OBJECTIVE: To determine whether sex steroid hormone concentrations are associated with kidney function or kidney damage in men in the general US population. We hypothesized that lower serum testosterone and E(2) concentrations are associated with CKD. DESIGN PATIENTS AND MEASUREMENTS: Serum sex steroid hormones were measured by electrochemiluminescence immunoassays for 1470 men who attended the morning session of Phase I of the Third National Health and Nutrition Examination Survey (NHANES III). We used two measures of CKD, estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m(2) calculated using serum creatinine or cystatin C levels and the abbreviated Modification of Diet in Renal Disease Study formulae and urinary albumin : creatinine ratio (UACR) >or= 17 mg/g. RESULTS: Mean free testosterone concentration was higher in men with an eGFR < 60 ml/min/1.73 m(2) than in men with a higher eGFR. In multivariable adjusted models, the odds of an eGFR < 60 ml/min/1.73 m(2) or UACR >/= 17 mg/g did not differ across tertiles of hormones with the exception of free E(2); those in the highest vs. lowest tertile had an elevated odds of decreased eGFR (OR: 3.04, 95% CI (1.22, 7.57); P-trend = 0.02). CONCLUSIONS: In a nationally representative sample of US adult men, higher free E(2) concentration was significantly associated with an eGFR < 60 ml/min/1.73 m(2) as assessed by serum creatinine or cystatin C even after multivariable adjustment. These findings are in contrast to the hypothesis that oestrogens may protect against CKD, though reverse causation cannot be ruled out. Longitudinal investigation of the role of oestrogens in kidney haemodynamics, function, and pathophysiology is warranted.
Authors: Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey Journal: Am J Kidney Dis Date: 2008-03 Impact factor: 8.860
Authors: Sabine Rohrmann; William G Nelson; Nader Rifai; Terry R Brown; Adrian Dobs; Norma Kanarek; James D Yager; Elizabeth A Platz Journal: J Clin Endocrinol Metab Date: 2007-04-24 Impact factor: 5.958
Authors: Tazeen H Jafar; Christopher H Schmid; Paul C Stark; Robert Toto; Giuseppe Remuzzi; Piero Ruggenenti; Carmelita Marcantoni; Gavin Becker; Shahnaz Shahinfar; Paul E De Jong; Dick De Zeeuw; Anne-Lise Kamper; Svend Strangaard; Andrew S Levey Journal: Nephrol Dial Transplant Date: 2003-10 Impact factor: 5.992
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Hypertension Date: 2003-11 Impact factor: 10.190
Authors: Catherine Kim; Ana C Ricardo; Edward J Boyko; Costas A Christophi; Marinella Temprosa; Karol E Watson; Xavier Pi-Sunyer; Rita R Kalyani Journal: J Clin Endocrinol Metab Date: 2019-04-01 Impact factor: 5.958
Authors: Channing J Paller; Meredith S Shiels; Sabine Rohrmann; Andy Menke; Nader Rifai; William G Nelson; Elizabeth A Platz; Adrian S Dobs Journal: J Androl Date: 2012-05-17
Authors: W Wulaningsih; M Van Hemelrijck; K Michaelsson; N Kanarek; W G Nelson; J H Ix; E A Platz; S Rohrmann Journal: Andrology Date: 2014-10-01 Impact factor: 3.842
Authors: Alison M Mondul; Elizabeth Selvin; Angelo M De Marzo; Stephen J Freedland; Elizabeth A Platz Journal: Cancer Causes Control Date: 2010-01-14 Impact factor: 2.506